aluates Reports

$ 0.0

Automative

Irritable Bowel Syndrome (IBS) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-36Z9952

Global Irritable Bowel Syndrome IBS Diagnostics Market Insights Forecast to 2028

BUY CHAPTERS

Irritable Bowel Syndrome (IBS) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36Z9952

Report

October 2024

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Commonwealth Diagnostics International

Genova Diagnostics

Prometheus Laboratories

Inova Diagnostics, Inc.

Biohit Oyj

Aerodiagnostics, LLC

Metabolic Solutions, Inc.

Sysmex Corporation

Gemelli Biotech

Buhlmann Laboratories AG

Irritable Bowel Syndrome (IBS) Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Irritable Bowel Syndrome (IBS) Diagnostics - Market

Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.

The global market for Irritable Bowel Syndrome (IBS) Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS) Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Irritable Bowel Syndrome (IBS) Diagnostics by region & country, by Type, and by Application.

The Irritable Bowel Syndrome (IBS) Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS) Diagnostics.

Market Segmentation

Scope of Irritable Bowel Syndrome (IBS) Diagnostics - Market Report

Report Metric	Details
Report Name	Irritable Bowel Syndrome (IBS) Diagnostics - Market
CAGR	5%
Segment by Type:	Laboratory Tests Imaging Tests
Segment by Application	Hospitals and Clinics Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc., Sysmex Corporation, Buhlmann Laboratories AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Irritable Bowel Syndrome (IBS) Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Irritable Bowel Syndrome (IBS) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Irritable Bowel Syndrome (IBS) Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Irritable Bowel Syndrome (IBS) Diagnostics - Market report?

Ans: The main players in the Irritable Bowel Syndrome (IBS) Diagnostics - Market are Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc., Sysmex Corporation, Buhlmann Laboratories AG

What are the Application segmentation covered in the Irritable Bowel Syndrome (IBS) Diagnostics - Market report?

Ans: The Applications covered in the Irritable Bowel Syndrome (IBS) Diagnostics - Market report are Hospitals and Clinics, Diagnostic Centers, Others

What are the Type segmentation covered in the Irritable Bowel Syndrome (IBS) Diagnostics - Market report?

Ans: The Types covered in the Irritable Bowel Syndrome (IBS) Diagnostics - Market report are Laboratory Tests, Imaging Tests

Recommended Reports

Digestive Disease Diagnostics

Digestive Drug Markets

Bowel Disorder Therapies

1 Market Overview

1.1 Irritable Bowel Syndrome (IBS) Diagnostics Product Introduction

1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Forecast

1.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Trends & Drivers

1.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Industry Trends

1.3.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers & Opportunity

1.3.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges

1.3.4 Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Players Revenue Ranking (2023)

2.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Irritable Bowel Syndrome (IBS) Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Irritable Bowel Syndrome (IBS) Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Irritable Bowel Syndrome (IBS) Diagnostics

2.6 Irritable Bowel Syndrome (IBS) Diagnostics Market Competitive Analysis

2.6.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Laboratory Tests

3.1.2 Imaging Tests

3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type

3.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals and Clinics

4.1.2 Diagnostic Centers

4.1.3 Others

4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application

4.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region

5.1.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

5.2.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

5.3.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

5.5.2 South America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Irritable Bowel Syndrome (IBS) Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Irritable Bowel Syndrome (IBS) Diagnostics Sales Value

6.3 United States

6.3.1 United States Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.3.2 United States Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.4.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.5.2 China Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.6.2 Japan Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019-2030

6.9.2 India Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Commonwealth Diagnostics International

7.1.1 Commonwealth Diagnostics International Profile

7.1.2 Commonwealth Diagnostics International Main Business

7.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.1.4 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 Commonwealth Diagnostics International Recent Developments

7.2 Genova Diagnostics

7.2.1 Genova Diagnostics Profile

7.2.2 Genova Diagnostics Main Business

7.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.2.4 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 Genova Diagnostics Recent Developments

7.3 Gemelli Biotech

7.3.1 Gemelli Biotech Profile

7.3.2 Gemelli Biotech Main Business

7.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.3.4 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Prometheus Laboratories Recent Developments

7.4 Prometheus Laboratories

7.4.1 Prometheus Laboratories Profile

7.4.2 Prometheus Laboratories Main Business

7.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.4.4 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Prometheus Laboratories Recent Developments

7.5 Inova Diagnostics, Inc.

7.5.1 Inova Diagnostics, Inc. Profile

7.5.2 Inova Diagnostics, Inc. Main Business

7.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.5.4 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Inova Diagnostics, Inc. Recent Developments

7.6 Biohit Oyj

7.6.1 Biohit Oyj Profile

7.6.2 Biohit Oyj Main Business

7.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.6.4 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 Biohit Oyj Recent Developments

7.7 Aerodiagnostics, LLC.

7.7.1 Aerodiagnostics, LLC. Profile

7.7.2 Aerodiagnostics, LLC. Main Business

7.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.7.4 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Aerodiagnostics, LLC. Recent Developments

7.8 Metabolic Solutions, Inc.

7.8.1 Metabolic Solutions, Inc. Profile

7.8.2 Metabolic Solutions, Inc. Main Business

7.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.8.4 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 Metabolic Solutions, Inc. Recent Developments

7.9 Sysmex Corporation

7.9.1 Sysmex Corporation Profile

7.9.2 Sysmex Corporation Main Business

7.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.9.4 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 Sysmex Corporation Recent Developments

7.10 Buhlmann Laboratories AG

7.10.1 Buhlmann Laboratories AG Profile

7.10.2 Buhlmann Laboratories AG Main Business

7.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

7.10.4 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Revenue (US$ Million) & (2019-2024)

7.10.5 Buhlmann Laboratories AG Recent Developments

8 Industry Chain Analysis

8.1 Irritable Bowel Syndrome (IBS) Diagnostics Industrial Chain

8.2 Irritable Bowel Syndrome (IBS) Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Irritable Bowel Syndrome (IBS) Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Irritable Bowel Syndrome (IBS) Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Commonwealth Diagnostics International

Genova Diagnostics

Prometheus Laboratories

Inova Diagnostics, Inc.

Biohit Oyj

Aerodiagnostics, LLC

Metabolic Solutions, Inc.

Sysmex Corporation

Gemelli Biotech

Buhlmann Laboratories AG

List of Tables

Table 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Trends

Table 2. Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers & Opportunity

Table 3. Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges

Table 4. Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints

Table 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Irritable Bowel Syndrome (IBS) Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Irritable Bowel Syndrome (IBS) Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Irritable Bowel Syndrome (IBS) Diagnostics

Table 10. Global Irritable Bowel Syndrome (IBS) Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Irritable Bowel Syndrome (IBS) Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. Commonwealth Diagnostics International Basic Information List

Table 32. Commonwealth Diagnostics International Description and Business Overview

Table 33. Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Commonwealth Diagnostics International (2019-2024)

Table 35. Commonwealth Diagnostics International Recent Developments

Table 36. Genova Diagnostics Basic Information List

Table 37. Genova Diagnostics Description and Business Overview

Table 38. Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Genova Diagnostics (2019-2024)

Table 40. Genova Diagnostics Recent Developments

Table 41. Gemelli Biotech Basic Information List

Table 42. Gemelli Biotech Description and Business Overview

Table 43. Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Gemelli Biotech (2019-2024)

Table 45. Gemelli Biotech Recent Developments

Table 46. Prometheus Laboratories Basic Information List

Table 47. Prometheus Laboratories Description and Business Overview

Table 48. Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Prometheus Laboratories (2019-2024)

Table 50. Prometheus Laboratories Recent Developments

Table 51. Inova Diagnostics, Inc. Basic Information List

Table 52. Inova Diagnostics, Inc. Description and Business Overview

Table 53. Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Inova Diagnostics, Inc. (2019-2024)

Table 55. Inova Diagnostics, Inc. Recent Developments

Table 56. Biohit Oyj Basic Information List

Table 57. Biohit Oyj Description and Business Overview

Table 58. Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Biohit Oyj (2019-2024)

Table 60. Biohit Oyj Recent Developments

Table 61. Aerodiagnostics, LLC. Basic Information List

Table 62. Aerodiagnostics, LLC. Description and Business Overview

Table 63. Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Aerodiagnostics, LLC. (2019-2024)

Table 65. Aerodiagnostics, LLC. Recent Developments

Table 66. Metabolic Solutions, Inc. Basic Information List

Table 67. Metabolic Solutions, Inc. Description and Business Overview

Table 68. Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Metabolic Solutions, Inc. (2019-2024)

Table 70. Metabolic Solutions, Inc. Recent Developments

Table 71. Sysmex Corporation Basic Information List

Table 72. Sysmex Corporation Description and Business Overview

Table 73. Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Sysmex Corporation (2019-2024)

Table 75. Sysmex Corporation Recent Developments

Table 76. Buhlmann Laboratories AG Basic Information List

Table 77. Buhlmann Laboratories AG Description and Business Overview

Table 78. Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Irritable Bowel Syndrome (IBS) Diagnostics Business of Buhlmann Laboratories AG (2019-2024)

Table 80. Buhlmann Laboratories AG Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Irritable Bowel Syndrome (IBS) Diagnostics Downstream Customers

Table 84. Irritable Bowel Syndrome (IBS) Diagnostics Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Product Picture

Figure 2. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Irritable Bowel Syndrome (IBS) Diagnostics Report Years Considered

Figure 5. Global Irritable Bowel Syndrome (IBS) Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2023

Figure 7. Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Laboratory Tests Picture

Figure 9. Imaging Tests Picture

Figure 10. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospitals and Clinics

Figure 13. Product Picture of Diagnostic Centers

Figure 14. Product Picture of Others

Figure 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Irritable Bowel Syndrome (IBS) Diagnostics Sales Value (%), (2019-2030)

Figure 28. United States Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 34. China Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 36. China Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 46. India Irritable Bowel Syndrome (IBS) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 48. India Irritable Bowel Syndrome (IBS) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 49. Irritable Bowel Syndrome (IBS) Diagnostics Industrial Chain

Figure 50. Irritable Bowel Syndrome (IBS) Diagnostics Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030

Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irritable Bowel Syndrome Medication Market Research Report 2025

Global In vitro Inflammatory Bowel Disease Diagnostic Market Research Report 2024

Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Small Intestinal Bacterial Overgrowth SIBO Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global IBS Probiotic Supplement Market Research Report 2024

Global Irritable Bowel Syndrome with Diarrhea IBS D Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IBS C Drugs Market Research Report 2024

Colorectal Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Idiopathic Constipation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digestive Drugs Market Insights Forecast to 2030

Global Digestive Distress Treatment Market Research Report 2024

Global IBS Implant Market Research Report 2024

Escherichia Coli E Coli Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions